Reassessing the Human Health Benefits from Cleaner Air

Risk Analysis

Volumn 32, Issue 5, 2012, Pages 816-829

  Cox, Louis Anthony Tony ^a  

^a University of Colordo ^*  (United States)

Author keywords

Air pollution health effects; Clean Air Act Amendment 1990; Risk cost benefit analysis; Uncertainty analysis; Weibull distribution

Indexed keywords

CAUSAL RELATIONS; CLEAN AIR ACT AMENDMENTS; COMPLIANCE COSTS; DISEASE PREVENTION; HEALTH BENEFITS; HEALTH EFFECTS; HUMAN HEALTH; LIFE EXPECTANCIES; MORTALITY RATE; MORTALITY RISK; POLICY MAKERS; POLLUTION EMISSIONS; POSITIVE PROBABILITY; RISK-COST-BENEFIT ANALYSIS;

AIR CLEANERS; AIR POLLUTION; COSTS; ENVIRONMENTAL PROTECTION AGENCY; HEALTH; UNCERTAINTY ANALYSIS; WEIBULL DISTRIBUTION;

HEALTH RISKS;

ASSESSMENT METHOD; ATMOSPHERIC POLLUTION; COST-BENEFIT ANALYSIS; EMISSION; HEALTH RISK; MORTALITY; POLLUTION EFFECT; PUBLIC HEALTH; UNCERTAINTY ANALYSIS; WEIBULL THEORY;

AIR POLLUTION; ARTICLE; GOVERNMENT; HUMAN; MORTALITY; PARTICLE SIZE; PRACTICE GUIDELINE; PROBABILITY; RISK ASSESSMENT; UNCERTAINTY; UNITED STATES;

AIR POLLUTION; GUIDELINE ADHERENCE; HUMANS; MORTALITY; PARTICLE SIZE; PROBABILITY; RISK ASSESSMENT; UNCERTAINTY; UNITED STATES; UNITED STATES ENVIRONMENTAL PROTECTION AGENCY;

EID: 84860498206     PISSN: 02724332     EISSN: 15396924     Source Type: Journal    
DOI: 10.1111/j.1539-6924.2011.01698.x     Document Type: Article

References (24)

1. EPA. The Benefits and Costs of the Clean Air Act from 1990 to 2020: Summary Report. EPA. March, 2011.
2. EPA. The Benefits and Costs of the Clean Air Act from 1990 to 2020. 2011.
3. Yabroff KR, Bradley CJ, Mariotto AB, Brown ML, Feuer EJ. Estimates and projections of value of life lost from cancer deaths in the United States. Journal of the National Cancer Institute, 2008; 100(24):1755-1762.
4. Aldy JE, Viscusi WK. Age differences in the value of statistical life: Revealed preference evidence. Review of Environmental Economics and Policy, 2007; 1(2):241-260.
5. Murphy K, Topel R. The economic value of medical research. Pp. 9-40 in Murphy K, Topel R (eds). Measuring the Gains from Economic Research: An Economic Approach. Chicago, IL: University of Chicago Press, 2003.
6. Gold M, Siegel JE, Russell LB, Weinstein MC (eds). Cost-Effectiveness in Health and Medicine. New York : Oxford University Press, 1996.
7. Cox LA Jr. An exposure-response threshold for lung diseases and lung cancer caused by crystalline silica. Risk Analysis, 2011; 31(10).
8. Stoeger T, Reinhard C, Takenaka S, Schroeppel A, Karg E, Ritter B, Heyder J, Schulz H. Instillation of six different ultrafine carbon particles indicates a surface area threshold dose for acute lung inflammation in mice. Environmental Health Perspectives, 2006; 114(3):328-333.
9. Clyde M. Model uncertainty and health effect studies for particulate matter. Environmetrics, 2000; 11(6):745- 763.
10. Koop G, Tole L. Measuring the health effects of air pollution: To what extent can we really say that people are dying from bad air? Journal of Environmental Economics and Management, 2004; 47:30-54. doi: Available at: Accessed October 12, 2011.
11. Koop G, Tole L. An investigation of thresholds in air pollution-mortality effects. Environmental Modelling & Software, 2006; 21(12):1662-1673.
12. Thomas DC, Jerrett M, Kuenzli N, Louis TA, Dominici F, Zeger S, Schwartz J, Burnett RT, Krewski D, Bates D. Bayesian model averaging in time-series studies of air pollution and mortality. Journal of Toxicology and Environmental Health Part A, 2007; 70(3-4):311-315.
13. Schwartz J, Coull B, Laden F, Ryan L. The effect of dose and timing of dose on the association between airborne particles and survival. Environmental Health Perspectives, 2008; 116(1):64-69.
14. Krewski, D, Jerrett M, Burnett RT, Ma R, Hughes E, Shi Y, et al. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality. Research Report (Health Effects Institute). 2009; 140:5-114.
15. Franklin M, Zeka A, Schwartz J. Association between PM2.5 and all-cause and specific-cause mortality in 27 US communities. Journal of Exposure Science and Environmental Epidemiology, 2007; 17(3):279-287.
16. Faes L, Nollo G, Chon KH. Assessment of Granger causality by nonlinear model identification: Application to short-term cardiovascular variability. Annals of Biomedical Engineering, 2008; 36(3):381-395.
17. Daniels MJ, Dominici F, Samet JM, Zeger SL. Estimating particulate matter-mortality dose-response curves and threshold levels: An analysis of daily time-series for the 20 largest US cities. American Journal of Epidemiology, 2000; 152(5): 397-406.
18. Roberts S, Martin MA. The question of nonlinearity in the dose-response relation between particulate matter air pollution and mortality: Can Akaike's information criterion be trusted to take the right turn? American Journal of Epidemiology, 2006; 164(12):1242-1250.
19. Sheppard L, Burnett RT, Szpiro A, Kim SY, Jerrett M, Pope CA, Brunekreef B. Confounding and exposure measurement error in air pollution. Air Quality, Atmosphere & Health, 2011, doi:.
20. Simkhovich BZ, Kleinman MT, Kloner RA. Particulate air pollution and coronary heart disease. Current Opinion in Cardiology, 2009; 24(6):604-609.
21. Simkhovich BZ, Kleinman MT, Kloner RA. Air pollution and cardiovascular injury epidemiology, toxicology, and mechanisms. Journal of the American College of Cardiology, 2008; 52(9):719-726.
22. Adabag AS, Luepker RV, Roger VL, Gersh BJ. Sudden cardiac death: Epidemiology and risk factors. Nature Reviews Cardiology, 2010; 7:216-225.
23. Capewell S, Ford ES, Croft JB, Critchley JA, Greenlund KJ, Labarthe DR. Cardiovascular risk factor trends and potential for reducing coronary heart disease mortality in the United States of America. Bulletin of the World Health Organization, 2010; 88(2):81-160.
24. Green LC, Armstrong SR. Particulate matter in ambient air and mortality: Toxicologic perspectives. Regulatory Toxicology and Pharmacology, 2003; 38(3):326-335.